Can B Corp. (OTCQB: CANB) Has Announced Expansion To Michigan Of Its Duramed Division's Sustained Acoustic Medicine (SAM) SAM Pro 2.0 Ultrasound Program Designed To Accelerate Tissue Healing And Reduce Chronic Pain; This Is First Time Insurance Covered

Can B Corp. (OTCQB: CANB) announces today (October 28, 2020) the expansion to the entire state of Michigan of its Duramed Division's Sustained Acoustic Medicine (SAM) Sam Pro 2.0 Ultrasound Program, replicating its initial success in New York and New Jersey. This insurance-covered revolutionary program is designed for accelerating tissue healing and reduction of chronic pain and is reimbursable by health insurance companies. It is cleared by the FDA and is made possible in Michigan for no-fault insurance via an agreement with Allcare Practice Management.

The Health And Wellness market has drawn intense interest from media companies. stockmarketpress.com features specialized coverage of related stocks such as Can B Corp. (OTCQB: CANB), Pfizer Inc. (NYSE: PFE), UnitedHealth Group Inc. (NYSE: UNH), Johnson & Johnson (NYSE: JNJ), Apple (NASDAQ: AAPL), HCA Healthcare (NYSE: HCA), Eli Lilly (NYSE: LLY), GlaxoSmithKline (NYSE: GSK), Biogen Inc. (NASDAQ: BIIB), Quidel Corp. (NASDAQ: QDEL), Health Catalyst (HCAT), Merck (NYSE: MRK), Peloton Interactive (NASDAQ: PTON), Fitbit (NYSE: FIT) and Natural Health Trends (NASDAQ: NHTC),

Can B Corp. (OTCQB: CANB) Has Announced Expansion To Michigan Of Its Duramed Division's Sustained Acoustic Medicine (SAM) SAM Pro 2.0 Ultrasound Program Designed To Accelerate Tissue Healing And Reduce Chronic Pain; This Is First Time Insurance Covered Program Is Expanding Beyond Original Success In New York And New Jersey

Duramed's SAM Pro 2.0 system is the first and only FDA cleared wearable, low intensity ultrasound multi-hour treatment to accelerate healing and improve function for musculoskeletal injuries ā€” such as muscle, tendon, ligament -- and reduce chronic pain, without opioid pain medication. Can B Corp. (OTCQB: CANB) Has Announced Expansion To Michigan Of Its Duramed Sustained Acoustic Medicine (SAM) SAM Pro 2.0 Ultrasound Program Designed To Accelerate Tissue Healing And Reduce Chronic Pain; This Is First Time Insurance Covered Program Is Expanding Beyond Original Success In New York And New Jersey.

Marco Alfonsi, CEO of Can B Corp. (OTCQB: CANB), said, "We are thrilled in achieving this milestone of expanding upon our success in New York and New Jersey with this revolutionary solution that addresses a much needed void in the market to accelerate tissue healing and chronic pain reduction. The unique SAM delivery delivery system, recurring revenue business model and our potential to add our proprietary CBD gels, is expected to drive our acceleration of revenue at improved gross margins over the next twelve months."

Duramed has a marketing strategy to provide equipment and services to both medical offices and direct to the consumer. The successful recurring business model calls for a rental rate per day, which is billed to the insurance company. The Duramed low-intensive ultrasound is a non-invasive, non-narcotic therapy for the daily treatment of musculoskeletal pain. On its website, Duramed explains the details of its clinically proven ultrasound program. Using a combination of the healing powers of CBD and state-of-the-art medical devices, the goal is for clients to live a healthy and fulfilling life. Duramed is a member of MAGNACARE, an industry organization that insures expedient processing and arbitration negotiation support.

Can B Corp.'s (OTCQB: CANB) Winning Diverse Marketing Strategies

This developing health and wellness company offers product through diverse marketing strategies: proprietary licensed brands, white labels, private labels through third parties and distribution through various channels such as retail, professional (physician), direct sales through its website and sales through subsidiaries. The company successfully places product in more than 1,100 retail outlets. Can B Corp. (OTCQB: CANB) Has Announced Expansion To Michigan Of Its Duramed Sustained Acoustic Medicine (SAM) SAM Pro 2.0 Ultrasound Program Designed To Accelerate Tissue Healing And Reduce Chronic Pain; This Is First Time Insurance Covered Program Is Expanding Beyond Original Success In New York And New Jersey.

Optimistic About The Future Financial Performance Of Can B Corp. (OTCQB: CANB)

Marco Alfonsi, CEO, is optimistic about the future financial performance of Can B Corp. (OTCQB: CANB) due in part to the strong gross margins of almost 77% the CBD company has achieved. In a report by site Bloomberg on CAN B Corp.'s (OTCQB: CANB) Q2 2020 financial results, the Company reported in the three month period ended June 30, 2020 that its gross profits rose 24% to 77% in 2020 from 53% in the comparable period in 2019. Can B Corp. (OTCQB: CANB) Has Announced Expansion To Michigan Of Its Duramed Division's Sustained Acoustic Medicine (SAM) SAM Pro 2.0 Ultrasound Program Designed To Accelerate Tissue Healing And Reduce Chronic Pain; This Is First Time Insurance Covered Program Is Expanding Beyond Original Success In New York And New Jersey.

Strong Gross Margins Of Almost 77% Help Drive Can B Corp.'s (OTCQB: CANB) Marco Alfonsi's, CEO, Optimism About The Company's Financial Performance

Marco Alfonsi, CEO of Can B Corp. (OTCQB: CANB), said, "We remain enthusiastic about our business prospects and returning to growth mode. Given our strong gross margins of almost 77%, -- 76.6% -- we feel confident in being able to return to the position we were earlier in 2020 when our revenue growth outpaced growth in expenses, as we achieved operating efficiencies."

A Health And Wellness Emerging Growth Company

Can B Corp. (OTCQB: CANB) offers an extensive line of drops/tinctures, oils, creams, moisturizers, chews, isolate, gel caps, concentrates and more. Its diverse proprietary product lines are available under license, private label and branded labels. This health and wellness emerging growth company offers lines of hemp derived CBD, CBD and non-CBD under license for the Lifeguard(R) lifestyle brand, Canbiola brand through physicians, products through white label and private label plus other subsidiaries.

Can B Corp. (OTCQB: CANB) Offers An Extensive Line Of CBD Products.

For more information, visit the company's website at canbcorp.com

Source: Stock Market Press

Join Stock Market Press' newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:

Statements in this news release may be "forward-looking statements." Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: http://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press

comtex tracking

COMTEX_373550155/2718/2020-10-28T07:53:51

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.